ChemoCentryx Q2 Loss Widens

ChemoCentryx Prices Follow-On Offering At $12/Shr - Quick Facts

ChemoCentryx Inc. (CCXI) Is Pulling Back After Offering Announcement

ChemoCentryx $60 Mln Stock Offering

Trade CCXI now with

8/10/2012 11:58 AM ET

ChemoCentryx, Inc. (CCXI: Quote) Friday reported a wider loss for the second quarter, due mainly to lower margins.

Net loss for the quarter widened to $10.9 million or $0.30 per share from $7.9 million or $1.90 per share in the same quarter last year.

Analysts polled by Thomson Reuters expected the company to earn $0.21 per share for the quarter. Analysts' estimates typically exclude special items.

Revenues totaled $1.1 million, down from $1.2 million last year.

Operating expenses increased to $12.2 million from $9.2 million last year.

Click here to receive FREE breaking news email alerts for ChemoCentryx Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

<<Previous 66 Articles Next>>

Editors Pick

China Manufacturing Contraction Deepens In June

China's manufacturing activity contracted at a faster pace in June, reducing the prospects of a promising economic recovery, preliminary results of a survey by Markit Economics and HSBC revealed Thursday. The flash manufacturing purchasing managers' index fell to 48.3 in June from 49.2 in May. The index is now at its lowest level in nine months.

King Makes Last Plea For Stimulus Before Entrusting BoE To Carney's 'Safe Hands'

Bank of England Governor Mervyn King made a last but strong call for expanding stimulus for the British economy in his final Mansion House speech on Wednesday even as he left some "unfinished business" in the banking sector for the next chief Mark Carney to complete. King will step down by end-June after ten years at the helm. Carney will assume office from July 1.

Red Hat Results Edge Past Estimates

Red Hat Inc., the world's largest seller of Linux software, said Wednesday after the markets closed that its first quarter profit rose 8% from last year, as revenue increased 15% amid strong consumer demand. The company's quarterly earnings per share, excluding items, also came in above analysts' expectations as did its quarterly revenue.